Menu Search
Equities

Giant Biogene Holding Co Ltd

2367:HKG

Giant Biogene Holding Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (HKD)37.25
  • Today's Change1.50 / 4.20%
  • Shares traded4.56m
  • 1 Year change0.00%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy10
Outperform11
Hold0
Sell0
Strong Sell0

Share price forecast in CNY

The 13 analysts offering 12 month price targets for Giant Biogene Holding Co Ltd have a median target of 56.63, with a high estimate of 63.97 and a low estimate of 43.04. The median estimate represents a 52.02% increase from the last price of 37.25.
High71.7%63.97
Med52.0%56.63
Low15.5%43.04

Dividends

In 2023, Giant Biogene Holding Co Ltd reported a dividend of 0.44 CNY. The 10 analysts covering the company expect dividends of 0.61 CNY for the upcoming fiscal year, an increase of 39.81%.
Div growth (TTM)--
More ▼

Earnings history & estimates in CNY

Giant Biogene Holding Co Ltd reported annual 2023 earnings of 1.48 per share on Mar 25, 2024.
Average growth rate+51.02%
More ▼

Revenue history & estimates in CNY

Giant Biogene Holding Co Ltd had revenues for the full year 2023 of 3.52bn. This was 49.05% above the prior year's results.
Average growth rate+49.05%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.